FDA Approves Validus's Bumex

Bumex is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.

Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route.

Successful treatment with Bumex following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.

Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as congestive heart failure, liver disease, and kidney disease. Getting rid of extra water helps to reduce fluid in the lungs so that you can breathe easier. It also helps to decrease swelling of the arms, legs, and stomach/abdomen. Bumetanide belongs to a class of drugs known as "water pills" (diuretics). It causes your body to get rid of extra water by increasing the amount of urine you make.

Bumex is used to lower the amount of excess salt and water in your body by increasing the output of urine. It is prescribed in the treatment of edema, or fluid retention, associated with congestive heart failure and liver or kidney disease. It is also occasionally prescribed, along with other drugs, to treat high blood pressure.

Bumex is a medication that is prescribed for the treatment of fluid retention. A type of diuretic, it works by increasing the amount of salt and water the kidneys remove from the blood, which causes a decrease in blood volume. Bumex comes in tablet form and is usually taken once a day. Potential side effects may include an electrolyte imbalance, dizziness, and nausea.